Comparison 8. Atypical antipsychotic vs antiparkinsonian.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
8.1 Adverse effects: gastrointestinal	1		Risk Ratio (IV, Random, 95% CI)	Subtotals only
8.1.1 Diarrhoea	1	18	Risk Ratio (IV, Random, 95% CI)	3.00 [0.14, 65.16]
8.1.2 Increased salivation	1	18	Risk Ratio (IV, Random, 95% CI)	3.00 [0.14, 65.16]
8.1.3 Vomiting	1	18	Risk Ratio (IV, Random, 95% CI)	0.20 [0.01, 3.66]
8.2 Adverse effects: metabolic	1		Risk Ratio (IV, Random, 95% CI)	Subtotals only
8.2.1 Decreased appetite	1	18	Risk Ratio (IV, Random, 95% CI)	0.09 [0.01, 1.44]
8.3 Adverse effects: neurological	1		Risk Ratio (IV, Random, 95% CI)	Subtotals only
8.3.1 Agitation/excitement	1	18	Risk Ratio (IV, Random, 95% CI)	1.50 [0.32, 6.94]
8.3.2 Increased hyperactivity	1	18	Risk Ratio (IV, Random, 95% CI)	7.00 [0.41, 118.69]
8.3.3 Insomnia	1	18	Risk Ratio (IV, Random, 95% CI)	2.00 [0.48, 8.31]
8.3.4 Sedation	1	18	Risk Ratio (IV, Random, 95% CI)	0.14 [0.01, 2.42]